A comprehensive association analysis of homocysteine metabolic pathway genes in singaporean Chinese with ischemic stroke

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Low, Hui Qi ^a   Chen, Christopher P L H ^b   Kasiman, Katherine ^b,c   Thalamuthu, Anbupalam ^a   Ng, Seok Shin ^a   Foo, Jia Nee ^a   Chang, Hui Meng ^d   Wong, Meng Cheong ^e   Tai, E Shyong ^b   Liu, Jianjun ^a  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c KAROLINSKA INSTITUTE   (Sweden)

^d NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; METHYLTRANSFERASE; TRANSCOBALAMIN II;

ADULT; AGED; ALLELE; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; REPLICATION STUDY; RISK ASSESSMENT; RISK FACTOR; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE PATIENT; ASIAN; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SINGAPORE; STROKE;

EID: 80052840956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024757     Document Type: Article

References (34)

1. Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, et al. (2003) Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101: 2483-2488.
2. Gellekink H, den Heijer M, Heil SG, Blom HJ, (2005) Genetic determinants of plasma total homocysteine. Semin Vasc Med 5: 98-109.
3. Wald DS, Law M, Morris JK, (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325: 1202.
4. Sudlow C, Martinez Gonzalez NA, Kim J, Clark C, (2006) Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke 37: 364-370.
5. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC, (2006) ACE polymorphisms. Circ Res 98: 1123-1133.
6. Casas JP, Hingorani AD, Bautista LE, Sharma P, (2004) Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61: 1652-1661.
7. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, et al. (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 35: 131-138.
8. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, et al. (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36: 233-239.
9. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288: 2015-2022.
10. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG, (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049-1057.
11. Moller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jorgensen PE, (2000) A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 60: 491-499.
12. Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G, (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43: 414-421.
13. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
14. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD, (2005) Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 365: 224-232.
15. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, et al. (1999) Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17: 29.
16. Laraqui A, Allami A, Carrie A, Coiffard AS, Benkouka F, et al. (2006) Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease. Acta Cardiol 61: 51-61.
17. Souto JC, Blanco-Vaca F, Soria JM, Buil A, Almasy L, et al. (2005) A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet 76: 925-933.
18. Kullo IJ, Ding K, Boerwinkle E, Turner ST, Mosley TH, et al. (2006) Novel genomic loci influencing plasma homocysteine levels. Stroke 37: 1703-1709.
19. Li Z, Sun L, Zhang H, Liao Y, Wang D, et al. (2003) Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke 34: 2085-2090.
20. Matarin M, Brown WM, Dena H, Britton A, De Vrieze FW, et al. (2009) Candidate gene polymorphisms for ischemic stroke. Stroke 40: 3436-3442.
21. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH, (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270: 2693-2698.
22. VITATOPS Trial Study Group (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 9: 855-865.
23. Tan CE, Emmanuel SC, Tan BY, Jacob E, (1999) Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 22: 241-247.
24. Cutter J, Tan BY, Chew SK, (2001) Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 79: 908-915.
25. The international HapMap Consortium (2003) The international HapMap project. Nature 426: 789-796.
26. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
27. R Development Core Team (2005) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
28. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
29. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
30. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
31. Stephens M, Scheet P, (2005) Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 76: 449-462.
32. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, et al. (2008) Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358: 910-919.
33. Gauderman WJ, Morrison JM, (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies.http://hydra.usc.edu/gxe.
34. Gauderman WJ, (2002) Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21: 35-50.